Hybrid Surgical and Endovascular Management of Ascending and Arch Dissection.

Historically, a variety of non-dissection proximal aortic pathologies with suitable anatomy have been treated with thoracic endovascular aortic repair (TEVAR) with high technical success rates. However, TEVAR use for acute type A aortic dissection has been extremely limited due to the unique challenging anatomic and clinical features and the lack of specifically-designed endoprostheses. These features include: proximity of the aortic valve, coronary arteries, and supra-aortic vessels, related aortic insufficiency, diffusely dilated aorta diameter, entry tear extension into the aortic root and/or aortic arch, the dissection involvement of supra-aortic vessels, high degrees of ascending aortic curvature and notable length discrepancies between the greater and lesser curvatures, and tissue fragility at prosthesis-tissue transition zones. Additionally, the presence of patent coronary artery bypass grafting conduits on the ascending aorta is another factor precluding endovascular options and hybrid surgical and endovascular approaches may be considered. In contrast, early feasibility clinical trials of investigational devices specifically designed to treat type A aortic dissections have been currently underway. In our opinion, the location and extent of intimal tears are quite variable and only a minority of patients with type A aortic dissection are deemed suitable candidates for ascending TEVAR. On the contrary, combined application of aortic arch endograft, as demonstrated in the present report, likely increases TEVAR candidacy as well as procedural success rates.